AAP Issues Guidelines for Children With Overweight, Obesity
Weight loss pharmacotherapy recommended as adjunct to health behavior and lifestyle treatment in children 12 years and older with obesity.
Source: clinicaladvisor.com
Stay updated with breaking news from Sarahe Hampl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Weight loss pharmacotherapy recommended as adjunct to health behavior and lifestyle treatment in children 12 years and older with obesity.
Weight loss pharmacotherapy recommended as adjunct to health behavior and lifestyle treatment in children 12 years and older with obesity.
Pediatric obesity is a serious disease and its prevalence has increased during the COVID-19 pandemic. Many factors can contribute to excess weight gain in youth including genetics/biology, the obesogenic environment, stress and sleep routines.